News Focus
News Focus
icon url

mrmainstreet

04/22/20 12:53 PM

#268336 RE: eightisenough #268331

Interesting, why do you think the generics consented to an expedited appeal? Don't they benefit from forcing AMRN to keep building the Vascepa market while the court fight wastes another year of exclusivity?